Yahoo
Shenzhen - Delayed Quote CNY

Aier Eye Hospital Group Co., Ltd. (300015.SZ)

8.68 +0.16 (+1.88%)
At close: 3:04:25 PM GMT+8
Chart Range Bar
Loading chart for 300015.SZ
  • Previous Close 8.52
  • Open 8.20
  • Bid 8.67 x --
  • Ask 8.68 x --
  • Day's Range 8.46 - 8.80
  • 52 Week Range 7.67 - 12.54
  • Volume 127,242,240
  • Avg. Volume 60,612,590
  • Market Cap (intraday) 80.559B
  • Beta (5Y Monthly) 0.38
  • PE Ratio (TTM) 33.38
  • EPS (TTM) 0.26
  • Earnings Date --
  • Forward Dividend & Yield 0.18 (2.11%)
  • Ex-Dividend Date Jul 17, 2026
  • 1y Target Est 12.14

Aier Eye Hospital Group Co., Ltd. operates as an ophthalmic medical company in China, Hong Kong, Europe, the United States, and Southeast Asia. It offers diagnosis and treatment services for various ophthalmic diseases, and surgical and medical optometry services, as well as lens fitting services for fundus diseases, glaucoma, and cataract. The company also provides training courses for cataract cases, ICL surgery, and presbyopia surgery. Aier Eye Hospital Group Co., Ltd. was founded in 2002 and is headquartered in Changsha, China.

www.aierchina.com

42,817

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

300015.SZ
19.51%
SSE Composite Index (000001.SS)
8.34%

1-Year Return

300015.SZ
27.86%
SSE Composite Index (000001.SS)
8.01%

3-Year Return

300015.SZ
50.47%
SSE Composite Index (000001.SS)
20.89%

5-Year Return

300015.SZ
66.79%
SSE Composite Index (000001.SS)
3.78%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 6.4B
Earnings 940.7M
Profit Margin 14.70%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
2B
4B
6B
0.0%
5.0%
10.0%

Analyst Insights

View More

Analyst Price Targets

7.50
12.14 Average
8.68 Current
15.79 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.44%

  • Return on Assets (ttm)

    8.65%

  • Return on Equity (ttm)

    11.04%

  • Revenue (ttm)

    23.21B

  • Net Income Avi to Common (ttm)

    2.42B

  • Diluted EPS (ttm)

    0.26

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.71B

  • Total Debt/Equity (mrq)

    31.62%

  • Levered Free Cash Flow (ttm)

    3.06B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: